Zoetis Inc. (ZOE.F)

141,00 +1,56 (+1,12%) Alla chiusura: 09:55PM CEST

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 14.100

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Ms. Kristin C. Peck	CEO & Director	3,32M	4,88M	1971
Mr. Wetteny N. Joseph	Executive VP & CFO	1,5M	N/D	1972
Ms. Wafaa Mamilli	EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health	1,27M	N/D	1967
Ms. Heidi C. Chen	Employee Advisor	1,16M	N/D	1967
Dr. Robert J. Polzer Ph.D.	Executive VP and President of Research & Development	1,1M	50,81k	1969
Ms. Roxanne Lagano	EVP, Chief HR Officer & Global Operations, Interim General Counsel and Corporate Secretary	N/D	N/D	1965
Mr. Steven Frank	Vice President of Investor Relations	N/D	N/D	N/D
Mr. William Price	VP & Chief Communications Officer	N/D	N/D	N/D
Ms. Jeannette Ferran Astorga	Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer	N/D	N/D	1975
Mr. Nick Ashton	Executive VP and President of Global Manufacturing & Supply	N/D	N/D	1973

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Governance aziendale

L'ISS Governance QualityScore di Zoetis Inc. al 1 aprile 2024 è 3. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 2; diritti degli azionisti: 7; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.